Le Lézard
Classified in: Science and technology, Business
Subject: SHAREHOLDER RIGHTS PLANS

Nioko Resources Files Early Warning Report in Respect of Orezone Gold Corporation


OUAGADOUGOU, Burkina Faso, Aug. 08, 2024 (GLOBE NEWSWIRE) -- This news release is issued by Nioko Resources Corporation ("Nioko Resources" or the "Acquiror") pursuant to the early warning requirements of Canada's National Instrument 62-104 and National Instrument 62-103 with respect to common shares (the "Common Shares") of Orezone Gold Corporation ("Orezone"), a reporting issuer in each of the Provinces and Territories of Canada with a head office at 450-505 Burrard St., Vancouver, British Columbia, V7X 1M3.

On August 8, 2024, the Acquiror acquired ownership of 92,743,855 Common Shares (the "Acquired Shares") issued from treasury at a price of C$0.70 per Acquired Share for aggregate consideration of C$64,920,698.50 (the "Equity Financing").

The Acquired Shares represent approximately 19.99% of the Common Shares issued and outstanding on closing of the Equity Financing. Prior to closing of the Equity Financing, Nioko Resources did not beneficially own or control or have direction over, directly or indirectly, any securities of Orezone.

The Acquiror acquired the Acquired Shares for investment purposes. Depending on market and other conditions, the Acquiror may increase or decrease its beneficial ownership, control or direction over Common Shares through market transactions, private agreements, treasury issuances, exercise of options, warrants, convertible securities or otherwise, in each case as investment conditions warrant.

An early warning report (the "Report") disclosing the acquisition of the beneficial ownership of the Acquired Shares under the Equity Financing will be filed on Orezone's SEDAR+ profile at www.sedarplus.ca and can be obtained from Nioko Resources, Ouagadougou, Secteur 54, Parcelle 02, Lot 17, Section 281(I), S/C 01 BP 2061, Ouagadougou 01, Burkina Faso, attention: Director General, by phone: (+226) 70 21 70 04 or by email: [email protected]. The Report updates an early warning report that was filed by the Acquiror on July 11, 2024.

About Nioko Resources Corporation

Nioko Resources is a West African investment group focused on regional growth.

Forward-Looking Statements

This news release may contain "forward-looking statements" within the meaning of applicable securities legislation, including statements regarding the filing of the Report and the disposition or acquisition of additional Common Shares or other securities of Orezone by Nioko Resources. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Except as required by law, Nioko Resources disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.

For further information:

Director General
Phone: (+226) 70 21 70 04
Email: [email protected].



These press releases may also interest you

at 14:28
ICEYE, the global leader in synthetic aperture radar (SAR) satellite operations for Earth Observation, persistent monitoring, and natural catastrophe solutions, has today announced signing the contract for the Greek National Satellite Space Project...

at 13:01
The AdvisorVault's 17a-4 Managed 365 Service includes full migration to Microsoft 365, a FINRA approved cybersecurity add on with a plug-in archiving data off the Microsoft cloud meeting the long-term electronic records retention & supervisory...

at 12:30
Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca's proprietary computational pathology platform, quantitative continuous scoring (QCS), was predictive of clinical outcomes in patients...

at 12:30
Results from an exploratory analysis of the TROPION-Lung01 phase 3 trial showed TROP2 as measured by quantitative continuous scoring (QCS), AstraZeneca's proprietary computational pathology platform, was predictive of clinical outcomes in patients...

at 11:50
Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced data from the primary analysis of the Phase III HARMONi-2 trial featuring the novel, potential first-in-class investigational bispecific antibody, ivonescimab. The data was...

at 11:05
Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today announced the creation of its reinsurance intermediary, Coalition Re, to provide capacity for cyber reinsurance treaties and expand on...



News published on and distributed by: